ProMedEx Approves Interim Dividend Authorization for 2026
PRO MEDEX 9574.SA | 0.00 |
Professional Medical Expertise Company (ProMedEx) announced on June 30, 2026 the results of its Ordinary General Assembly Meeting held on June 29, 2026 at its Dhahran headquarters via modern technology, with 49.84274% shareholder attendance. The assembly approved multiple resolutions including SAR 100,000 remuneration for Chairman Dr. Samir Sulaiman Al-Omran, authorization for the Board to distribute interim dividends on semi-annual or quarterly basis for 2026, and appointment of RSM Allied Accountants as external auditor for 2026 with fees of SAR 420,000. Additional approvals included the appointment of Mr. Adel Abdulaziz Ahmed Boudi as Independent Board Member effective May 30, 2026 to complete the current term ending December 27, 2026, and delegation of certain Ordinary General Assembly powers to the Board of Directors for one year.
Original announcement:
https://www.saudiexchange.sa/wps/portal/saudiexchange/newsandreports/issuer-news/issuer-announcements/issuer-announcements-details/?anId=96500&anCat=1&cs=9574&locale=arAttached PDF document link:
https://www.saudiexchange.sa/Resources/fsPdf/16610_4631_2026-06-29_23-05-20_en.pdfImportant Notice: The announcement information and market data in this report are sourced directly from the Saudi Exchange (Tadawul). This summary is generated by Sahm’s proprietary AI model for informational purposes only. While we strive for accuracy, it should not be construed as financial advice or an investment recommendation.
